Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 689
Filter
1.
Methods Mol Biol ; 2775: 375-384, 2024.
Article in English | MEDLINE | ID: mdl-38758331

ABSTRACT

Advances in understanding cellular aging research have been possible due to the analysis of the replicative lifespan of yeast cells. Studying longevity in the pathogenic yeast Cryptococcus neoformans is essential because old yeast cells with age-related phenotypes accumulate during infection and are associated with increased virulence and antifungal tolerance. Microdissection and microfluidic devices are valuable tools for continuously tracking cells at the single-cell level. In this chapter, we describe the features of these two platforms and outline technical limitations and information to study aging mechanisms while assessing the lifespan of yeast cells.


Subject(s)
Cryptococcus neoformans , Cryptococcus neoformans/physiology , Cryptococcus neoformans/growth & development , Microdissection/methods , Cellular Senescence , Lab-On-A-Chip Devices , Single-Cell Analysis/methods , Cryptococcosis/microbiology
2.
mSphere ; 8(6): e0029923, 2023 Dec 20.
Article in English | MEDLINE | ID: mdl-37850793

ABSTRACT

IMPORTANCE: Eukaryotic gene transcription is typically regulated by a series of histone modifications, which play a crucial role in adapting to complex environmental stresses. In the ubiquitous human fungal pathogen Cryptococcus neoformans, sexual life cycle is a continuous intracellular differentiation process that strictly occurs in response to mating stimulation. Despite the comprehensive identification of the regulatory factors and genetic pathways involved in its sexual cycle, understanding of the epigenetic modifications involved in this process remains quite limited. In this research, we found that histone acetyltransferase Gcn5-mediated histone H3 acetylation plays a crucial role in completing the cryptococcal sexual cycle, including yeast-hyphae morphogenesis and the subsequent sexual reproduction. Furthermore, we demonstrated that Gcn5 participates in this process primarily through regulating the key morphogenesis regulator Znf2 and its targets. This study thus provided a comprehensive understanding of how histone acetylation modification impacts sexual life cycle in a high-risk human pathogenic fungus.


Subject(s)
Cryptococcus neoformans , Histones , Humans , Acetylation , Cryptococcus neoformans/growth & development , Cryptococcus neoformans/physiology , Fungal Proteins/metabolism , Histone Acetyltransferases/genetics , Histone Acetyltransferases/metabolism , Histones/genetics , Life Cycle Stages , Reproduction
3.
Nat Commun ; 13(1): 7938, 2022 12 24.
Article in English | MEDLINE | ID: mdl-36566249

ABSTRACT

Pathogenic fungi of the genus Cryptococcus can undergo two sexual cycles, involving either bisexual diploidization (after fusion of haploid cells of different mating type) or unisexual diploidization (by autodiploidization of a single cell). Here, we construct a gene-deletion library for 111 transcription factor genes in Cryptococcus deneoformans, and explore the roles of these regulatory networks in the two reproductive modes. We show that transcription factors crucial for bisexual syngamy induce the expression of known mating determinants as well as other conserved genes of unknown function. Deletion of one of these genes, which we term FMP1, leads to defects in bisexual reproduction in C. deneoformans, its sister species Cryptococcus neoformans, and the ascomycete Neurospora crassa. Furthermore, we show that a recently evolved regulatory cascade mediates pre-meiotic unisexual autodiploidization, supporting that this reproductive process is a recent evolutionary innovation. Our findings indicate that genetic circuits with different evolutionary ages govern hallmark events distinguishing unisexual and bisexual reproduction in Cryptococcus.


Subject(s)
Cryptococcus neoformans , Fungal Proteins , Meningitis, Cryptococcal , Cryptococcus neoformans/growth & development , Cryptococcus neoformans/pathogenicity , Fungal Proteins/genetics , Fungal Proteins/metabolism , Genes, Mating Type, Fungal/genetics , Reproduction, Asexual/genetics , Meningitis, Cryptococcal/parasitology
4.
Fungal Genet Biol ; 160: 103697, 2022 05.
Article in English | MEDLINE | ID: mdl-35472450

ABSTRACT

Cryptococcus neoformans, a basidiomycete yeast, causes lethal meningitis in immunocompromised individuals. The ability of C. neoformans to proliferate at 37°C is essential for virulence. We identified anillin-like protein, CnBud4, as essential for proliferation of C. neoformans at 37°C and for virulence in a heterologous host Galleria mellonella at 25°C. C. neoformans cells lacking CnBud4 were inviable at 25°C in the absence of active calcineurin and were hypersensitive to membrane stress and an anti-fungal agent fluconazole, phenotypes previously described for C. neoformans mutants lacking septins. CnBud4 localized to the mother-bud neck during cytokinesis in a septin-dependent manner. In the absence of CnBud4, septin complex failed to transition from a collar-like single ring to the double ring during cytokinesis. In an ascomycete yeast, Saccharomyces cerevisiae, the anillin-like homologue ScBud4 participates in the organization of the septin ring at the mother-bud neck and plays an important role in specifying location for new bud emergence, known as axial budding pattern. In contrast to their role in S. cerevisiae, neither septins nor CnBud4 were needed to direct the position of the new bud in C. neoformans, suggesting that this function is not conserved in basidiomycetous yeasts. Our data suggest that the requirement of CnBud4 for growth at 37°C and pathogenicity in C. neoformans is based on its conserved role in septin complex organization.


Subject(s)
Body Temperature , Contractile Proteins , Cryptococcus neoformans , Cryptococcosis/microbiology , Cryptococcus neoformans/growth & development , Cryptococcus neoformans/pathogenicity , Host Microbial Interactions , Humans , Saccharomyces cerevisiae , Saccharomyces cerevisiae Proteins , Septins/metabolism
5.
Mar Drugs ; 20(3)2022 Mar 07.
Article in English | MEDLINE | ID: mdl-35323494

ABSTRACT

Six new ß-resorcylic acid derivatives (1-5 and 7) were isolated from a halophyte-associated fungus, Colletotrichum gloeosporioides JS0419, together with four previously reported ß-resorcylic acid lactones (RALs). The relative and absolute stereochemistry of 1 was completely established by a combination of spectroscopic data and chemical reactions. The structures of the isolated compounds were elucidated by analysis of HRMS and NMR data. Notably, compounds 1-3 had a ß-resorcylic acid harboring a long unesterified aliphatic side chain, whereas the long aliphatic chains were esterified to form macrolactones in 4-9. Among the isolated compounds, monocillin I and radicicol showed potent antifungal activities against Cryptococcus neoformans, comparable to clinically available antifungal agents and radicicol showed weak antifungal activity against Candida albicans. These findings provide insight into the chemical diversity of fungal RAL-type compounds and their pharmacological potential.


Subject(s)
Antifungal Agents/pharmacology , Candida albicans/drug effects , Chenopodiaceae/microbiology , Colletotrichum/chemistry , Cryptococcus neoformans/drug effects , Hydroxybenzoates/pharmacology , Salt-Tolerant Plants/microbiology , Antifungal Agents/chemistry , Antifungal Agents/isolation & purification , Candida albicans/growth & development , Cryptococcus neoformans/growth & development , Hydroxybenzoates/chemistry , Hydroxybenzoates/isolation & purification , Molecular Structure , Stereoisomerism
6.
Molecules ; 26(24)2021 Dec 08.
Article in English | MEDLINE | ID: mdl-34946516

ABSTRACT

The azo-azomethine imines, R1-N=N-R2-CH=N-R3, are a class of active pharmacological ligands that have been prominent antifungal, antibacterial, and antitumor agents. In this study, four new azo-azomethines, R1 = Ph, R2 = phenol, and R3 = pyrazol-Ph-R' (R = H or NO2), have been synthesized, structurally characterized using X-ray, IR, NMR and UV-Vis techniques, and their antifungal activity evaluated against certified strains of Candida albicans and Cryptococcus neoformans. The antifungal tests revealed a high to moderate inhibitory activity towards both strains, which is regulated as a function of both the presence and the location of the nitro group in the aromatic ring of the series. These biological assays were further complemented with molecular docking studies against three different molecular targets from each fungus strain. Molecular dynamics simulations and binding free energy calculations were performed on the two best molecular docking results for each fungus strain. Better affinity for active sites for nitro compounds at the "meta" and "para" positions was found, making them promising building blocks for the development of new Schiff bases with high antifungal activity.


Subject(s)
Antifungal Agents , Candida albicans/growth & development , Cryptococcus neoformans/growth & development , Molecular Docking Simulation , Molecular Dynamics Simulation , Pyrazoles , Antifungal Agents/chemical synthesis , Antifungal Agents/chemistry , Antifungal Agents/pharmacology , Pyrazoles/chemical synthesis , Pyrazoles/chemistry , Pyrazoles/pharmacology
7.
mBio ; 12(6): e0327321, 2021 12 21.
Article in English | MEDLINE | ID: mdl-34933457

ABSTRACT

Histone chaperoning ensures genomic integrity during routine processes such as DNA replication and transcription as well as DNA repair upon damage. Here, we identify a nuclear J domain protein, Dnj4, in the fungal pathogen Cryptococcus neoformans and demonstrate that it interacts with histones 3 and 4, suggesting a role as a histone chaperone. In support of this idea, a dnj4Δ deletion mutant had elevated levels of DNA damage and was hypersensitive to DNA-damaging agents. The transcriptional response to DNA damage was also impaired in the dnj4Δ mutant. Genes related to DNA damage and iron homeostasis were upregulated in the wild-type strain in response to hydroxyurea treatment; however, their upregulation was either absent from or reduced in the dnj4Δ mutant. Accordingly, excess iron rescued the mutant's growth in response to DNA-damaging agents. Iron homeostasis is crucial for virulence in C. neoformans; however, Dnj4 was found to be dispensable for disease in a mouse model of cryptococcosis. Finally, we confirmed a conserved role for Dnj4 as a histone chaperone by expressing it in Saccharomyces cerevisiae and showing that it disrupted endogenous histone chaperoning. Altogether, this study highlights the importance of a JDP cochaperone in maintaining genome integrity in C. neoformans. IMPORTANCE DNA replication, gene expression, and genomic repair all require precise coordination of the many proteins that interact with DNA. This includes the histones as well as their chaperones. In this study, we show that a histone chaperone, Dnj4, is required for genome integrity and for the response to DNA damage. The gene encoding this protein in Cryptococcus neoformans lacks an ortholog in Saccharomyces cerevisiae; however, it is conserved in humans in which its ortholog is essential. Since it is not essential in C. neoformans, we were able to generate deletion mutants to characterize the roles of Dnj4. We also expressed Dnj4 in S. cerevisiae, in which it was able to bind S. cerevisiae histones and interfere with existing histone chaperoning machinery. Therefore, we show a conserved role for Dnj4 in histone chaperoning that suggests that C. neoformans is useful to better understand aspects of this important biological process.


Subject(s)
Cryptococcosis/microbiology , Cryptococcus neoformans/genetics , Cryptococcus neoformans/metabolism , DNA Damage , Fungal Proteins/metabolism , Histone Chaperones/metabolism , Cryptococcus neoformans/chemistry , Cryptococcus neoformans/growth & development , Fungal Proteins/genetics , Gene Expression Regulation, Fungal , Histone Chaperones/chemistry , Histone Chaperones/genetics , Histones/genetics , Histones/metabolism , Humans , Iron/metabolism , Protein Binding , Protein Domains
8.
mBio ; 12(4): e0167221, 2021 08 31.
Article in English | MEDLINE | ID: mdl-34311572

ABSTRACT

There is a critical need for new antifungal drugs; however, the lack of available fungus-specific targets is a major hurdle in the development of antifungal therapeutics. Spore germination is a differentiation process absent in humans that could harbor uncharacterized fungus-specific targets. To capitalize on this possibility, we developed novel phenotypic assays to identify and characterize inhibitors of spore germination of the human fungal pathogen Cryptococcus. Using these assays, we carried out a high-throughput screen of ∼75,000 drug-like small molecules and identified and characterized 191 novel inhibitors of spore germination, many of which also inhibited yeast replication and demonstrated low cytotoxicity against mammalian cells. Using an automated, microscopy-based, quantitative germination assay (QGA), we discovered that germinating spore populations can exhibit unique phenotypes in response to chemical inhibitors. Through the characterization of these spore population dynamics in the presence of the newly identified inhibitors, we classified 6 distinct phenotypes based on differences in germination synchronicity, germination rates, and overall population behavior. Similar chemical phenotypes were induced by inhibitors that targeted the same cellular function or had shared substructures. Leveraging these features, we used QGAs to identify outliers among compounds that fell into similar structural groups and thus refined relevant structural moieties, facilitating target identification. This approach led to the identification of complex II of the electron transport chain as the putative target of a promising structural cluster of germination inhibitory compounds. These inhibitors showed high potency against Cryptococcus spore germination while maintaining low cytotoxicity against mammalian cells, making them prime candidates for development into novel antifungal therapeutics. IMPORTANCE Fungal pathogens cause 1.5 million deaths annually, and there is a critical need for new antifungal drugs. However, humans and fungi are very similar on a molecular level, and so many drugs that kill fungi also damage human cells, leading to extreme side effects, including death. The lack of fungus-specific targets is a major hurdle in the development of antifungal therapeutics. Spore germination is a process absent in humans that could harbor fungus-specific targets. To capitalize on this possibility, we developed new assays to identify and characterize inhibitors of spore germination of the human fungal pathogen Cryptococcus. Using these assays, we identified and characterized 191 novel inhibitors of spore germination. These inhibitors showed high potency against Cryptococcus spore germination while maintaining low cytotoxicity against mammalian cells, making them prime candidates for development into novel antifungal therapeutics.


Subject(s)
Antifungal Agents/pharmacology , Cryptococcus neoformans/drug effects , Spores, Fungal/drug effects , Spores, Fungal/growth & development , Cryptococcosis/drug therapy , Cryptococcus neoformans/growth & development , Cryptococcus neoformans/pathogenicity , Drug Discovery , High-Throughput Screening Assays , Humans , Phenotype , Spores, Fungal/classification , Spores, Fungal/pathogenicity
9.
Bioorg Med Chem ; 44: 116293, 2021 08 15.
Article in English | MEDLINE | ID: mdl-34243044

ABSTRACT

Antifungal development has gained increasing attention due to its limited armamentarium and drug resistance. Drug repurposing holds great potential in antifungal discovery. In this study, we explored the antifungal activity of artemisinin and its derivatives, dihydroartemisinin, artesunate and artemether. We identified that artemisinins can inhibit the growth of Candida albicans, and can enhance the activity of three commonly used antifungals, amphotericin B, micafungin and fluconazole (FLC), on Candida albicans growth and filamentation. Artemisinins possess stronger antifungal effect with FLC than with other antifungals. Among artemisinins, artemether exhibits the most potent antifungal activity with FLC and can recover the susceptibility of FLC-resistant clinical isolates to FLC treatment. The combinatorial antifungal activity of artemether and FLC is broad-spectrum, as it can inhibit the growth of Candida auris, Candida tropicalis, Candida parapsilosis, Saccharomyces cerevisiae and Cryptococcus neoformans. Mechanistic investigation revealed that artemether might enhance azole efficacy through disrupting the function of Pdr5, leading to intracellular accumulation of FLC. This study identified artemether as a novel FLC potentiator, providing potential therapeutic insights against fungal infection and antifungal resistance.


Subject(s)
ATP-Binding Cassette Transporters/antagonists & inhibitors , Antifungal Agents/pharmacology , Artemisinins/pharmacology , Fluconazole/pharmacology , Candida/drug effects , Candida/growth & development , Cryptococcus neoformans/drug effects , Cryptococcus neoformans/growth & development , Dose-Response Relationship, Drug , Microbial Sensitivity Tests , Molecular Structure , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/growth & development , Structure-Activity Relationship
11.
Microbiology (Reading) ; 167(6)2021 06.
Article in English | MEDLINE | ID: mdl-34125663

ABSTRACT

The CAP64 gene is known to be involved in capsule formation in the basidiomycete yeast Cryptococcus neoformans. A null mutant of CAP64, Δcap64, lacks a capsule around the cell wall and its acidic organelles are not stained with quinacrine. In order to clarify whether the Cap64 protein indeed maintains vacuole or vesicle acidification, so that the vesicle containing the capsule polysaccharide or DBB substrate are transported to the cell membrane side, the relationship between CAP64 and intracellular transport genes and between CAP64 and enzyme-secretion activity were analysed. Laccase activity was higher in the Δcap64 strain than in the wild-type strain, and the transcriptional levels of SAV1 and VPH1 were also higher in the Δcap64 strain than in the wild-type strain. The intracellular localization of the Cap64 protein was analysed by overexpressing an mCherry-tagged Cap64 and observing its fluorescence. The Cap64 protein was accumulated within cells in a patch-like manner. The quinacrine-stained cells were observed to analyse the acidified cell compartments; quinacrine was found to be accumulated in a patch-like manner, with the patches overlapping the fluorescence of CAP64-mCherry fusion protein. Quinacrine was thus accumulated in a patch-like fashion in the cells, and the mCherry-tagged Cap64 protein position was consistent with the position of quinacrine accumulation in cells. These results suggest that CAP64 might be involved in intracellular acidification and vesicle secretion via exocytosis.


Subject(s)
Cryptococcosis/microbiology , Cryptococcus neoformans/metabolism , Fungal Proteins/metabolism , Polysaccharides/biosynthesis , Cryptococcus neoformans/chemistry , Cryptococcus neoformans/genetics , Cryptococcus neoformans/growth & development , Fungal Proteins/genetics , Homeostasis , Humans , Hydrogen-Ion Concentration , Protein Transport , Vacuoles/chemistry , Vacuoles/metabolism
12.
J Microbiol Methods ; 177: 106046, 2020 10.
Article in English | MEDLINE | ID: mdl-32920020

ABSTRACT

We prepared a newer growth medium, banana peel extract agar (BPEA) containing the extracts of chopped banana peels for the selective cultivation of Cryptococcus neoformans. Over the medium, the growth resulted in the development of light to the dark brown coloured colonies indicating the chromogenic potential of the BPEA. The organism grown over BPEA was subsequently confirmed as C. neoformans by phenotypic as well as by molecular method. This medium, being cost-effective, may be used in resource-poor settings of the developing or underdeveloped countries for selective isolation of C. neoformans.


Subject(s)
Bacteriological Techniques/methods , Cryptococcus neoformans/growth & development , Cryptococcus neoformans/isolation & purification , Culture Media/chemistry , Musa/chemistry , Plant Extracts/chemistry , Agar , Cerebrospinal Fluid/microbiology , Cryptococcosis/cerebrospinal fluid , Cryptococcosis/diagnosis , Cryptococcosis/microbiology , Cryptococcus neoformans/genetics , DNA, Bacterial/isolation & purification , Meningoencephalitis/cerebrospinal fluid , Meningoencephalitis/diagnosis , Meningoencephalitis/microbiology
13.
Microbiol Res ; 241: 126570, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32805526

ABSTRACT

Invasive growth of yeast cells into nutrient agar is induced by different stresses and contributes to the survival of yeast cells under several adverse conditions. The mechanism of invasive growth of Saccharomyces cerevisiae has been extensively investigated. However, there is very little information about the mechanism of invasive growth of another human pathogen yeast Cryptococcus neoformans. Here, we report that deletion of a small and secreted cysteine-rich protein Cpl1 in C. neoformans JEC21 leads to increased adhesive and invasive growth into nutrient agar. The increased adhesive and invasive growth does not depend on the only known adhesion protein Cfl1 and its main controller Znf2. Cpl1Δ accumulates significantly higher level of intracellular labile zinc ion, leading to increased glucose uptake, higher level of mitochondrial membrane potential, ATP and Reactive Oxygen Species(ROS) production. Higher level of ROS activates Snf1, leading to invasive growth of Cpl1Δ. Three cysteine residues at the N-terminals of the cysteine-rich domain controls the increased invasive growth under nutrient sufficient conditions. This is the first report that a small and secreted cysteine-rich protein negatively regulates invasive growth of C. neoformans through regulating the intracellular labile zinc ion level. The function of this cysteine-rich domain was systematically investigated by site-directed mutagenensis in C. neoformans. The work contributes to understanding the function of this protein family and the invasive growth mechanism in C. neoformans.


Subject(s)
Cryptococcus neoformans/growth & development , Cryptococcus neoformans/metabolism , Fungal Proteins/metabolism , Adenosine Triphosphate/biosynthesis , Agar , CRISPR-Cas Systems/genetics , Cysteine/chemistry , Fungal Proteins/genetics , Gene Expression Regulation, Fungal , Membrane Potential, Mitochondrial/physiology , Reactive Oxygen Species/metabolism , Virulence , Zinc/chemistry
14.
Infect Immun ; 88(8)2020 07 21.
Article in English | MEDLINE | ID: mdl-32482643

ABSTRACT

Immune response to pathogens is energetically expensive to the host; however, the cellular source of energy to fuel immune response remains unknown. In this study, we show that Caenorhabditis elegans exposed to pathogenic Gram-positive and Gram-negative bacteria or yeast rapidly utilizes lipid droplets, the major energy reserve. The nematode's response to the pathogenic bacterium Enterococcus faecalis entails metabolic rewiring for the upregulation of several genes involved in lipid utilization and downregulation of lipid synthesis genes. Genes encoding acyl-CoA synthetase ACS-2, involved in lipid metabolism, and flavin monooxygenase FMO-2, involved in detoxification, are two highly upregulated genes during E. faecalis infection. We find that both ACS-2 and FMO-2 are necessary for survival and rely on NHR-49, a peroxisome proliferator-activated receptor alpha (PPARα) ortholog, for upregulation during E. faecalis infection. Thus, NHR-49 regulates an immunometabolic axis of survival in C. elegans by modulating breakdown of lipids as well as immune effector production upon E. faecalis exposure.


Subject(s)
Caenorhabditis elegans Proteins/genetics , Caenorhabditis elegans/immunology , Coenzyme A Ligases/genetics , Enterococcus faecalis/immunology , Lipid Metabolism/immunology , Oxygenases/genetics , Receptors, Cytoplasmic and Nuclear/genetics , Animals , Caenorhabditis elegans/genetics , Caenorhabditis elegans/metabolism , Caenorhabditis elegans/microbiology , Caenorhabditis elegans Proteins/immunology , Coenzyme A Ligases/immunology , Cryptococcus neoformans/growth & development , Cryptococcus neoformans/immunology , Enterococcus faecalis/growth & development , Gene Expression Profiling , Gene Expression Regulation , Host-Pathogen Interactions/genetics , Host-Pathogen Interactions/immunology , Immunity, Innate , Lipid Droplets/immunology , Lipid Droplets/metabolism , Longevity/genetics , Longevity/immunology , Oxygenases/immunology , Pseudomonas aeruginosa/growth & development , Pseudomonas aeruginosa/immunology , Receptors, Cytoplasmic and Nuclear/immunology , Signal Transduction
15.
FEMS Yeast Res ; 20(4)2020 06 01.
Article in English | MEDLINE | ID: mdl-32490521

ABSTRACT

Cryptococcal urease is believed to be important for the degradation of exogenous urea that the yeast encounters both in its natural environment and within the human host. Endogenous urea produced by the yeast's own metabolic reactions, however, may also serve as a substrate for the urease enzyme. Using wild-type, urease-deletion mutant and urease-reconstituted strains of Cryptococcus neoformans H99, we studied reactions located up- and downstream from endogenous urea. We demonstrated that urease is important for cryptococcal growth and that, compared to nutrient-rich conditions at 26°C, urease activity is higher under nutrient-limited conditions at 37°C. Compared to cells with a functional urease enzyme, urease-deficient cells had significantly higher intracellular urea levels and also showed more arginase activity, which may act as a potential source of endogenous urea. Metabolic reactions linked to arginase were also affected, since urease-positive and urease-negative cells differed with respect to agmatinase activity, polyamine synthesis, and intracellular levels of proline and reactive oxygen species. Lastly, urease-deficient cells showed higher melanin levels at 26°C than wild-type cells, while the inverse was observed at 37°C. These results suggest that cryptococcal urease is associated with the functioning of key metabolic pathways within the yeast cell.


Subject(s)
Cryptococcus neoformans/enzymology , Cryptococcus neoformans/pathogenicity , Metabolic Networks and Pathways , Urea/metabolism , Urease/genetics , Virulence Factors/metabolism , Cryptococcus neoformans/growth & development , Cryptococcus neoformans/metabolism , Humans , Microbial Viability , Urease/metabolism , Virulence
16.
FASEB J ; 34(7): 8902-8919, 2020 07.
Article in English | MEDLINE | ID: mdl-32519783

ABSTRACT

TOKs are outwardly rectifying K+ channels in fungi with two pore-loops and eight transmembrane spans. Here, we describe the TOKs from four pathogens that cause the majority of life-threatening fungal infections in humans. These TOKs pass large currents only in the outward direction like the canonical isolate from Saccharomyces cerevisiae (ScTOK), and distinct from other K+ channels. ScTOK, AfTOK1 (Aspergillus fumigatus), and H99TOK (Cryptococcus neoformans grubii) are K+ -selective and pass current above the K+ reversal potential. CaTOK (Candida albicans) and CnTOK (Cryptococcus neoformans neoformans) pass both K+ and Na+ and conduct above a reversal potential reflecting the mixed permeability of their selectivity filter. Mutations in CaTOK and ScTOK at sites homologous to those that open the internal gates in classical K+ channels are shown to produce inward TOK currents. A favored model for outward rectification is proposed whereby the reversal potential determines ion occupancy, and thus, conductivity, of the selectivity filter gate that is coupled to an imperfectly restrictive internal gate, permitting the filter to sample ion concentrations on both sides of the membrane.


Subject(s)
Electric Conductivity , Ion Channel Gating/physiology , Oocytes/physiology , Potassium Channels/physiology , Potassium/metabolism , Amino Acid Sequence , Animals , Candida albicans/genetics , Candida albicans/growth & development , Candida albicans/metabolism , Cloning, Molecular , Computational Biology , Cryptococcus neoformans/genetics , Cryptococcus neoformans/growth & development , Cryptococcus neoformans/metabolism , Membrane Potentials , Oocytes/cytology , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae/metabolism , Sequence Homology , Xenopus laevis
17.
Genes (Basel) ; 11(6)2020 06 19.
Article in English | MEDLINE | ID: mdl-32575488

ABSTRACT

The heterothallic basidiomycetous fungus Cryptococcus neoformans has two mating types, MATa and MATα. Morphological progression of bisexual reproduction in C. neoformans is as follows: yeast to hyphal transition, filament extension, basidium formation, meiosis, and sporulation. C. neoformans Cdk-related kinase 1 (CRK1) is a negative regulator of bisexual mating. In this study, we characterized the morphological features of mating structures in the crk1 mutant and determined the genetic interaction of CRK1 in the regulatory networks of sexual differentiation. In the bilateral crk1 mutant cross, despite shorter length of filaments than in the wild-type cross, dikaryotic filaments and other structures still remained intact during bisexual mating, but the timing of basidium formation was approximately 18 h earlier than in the cross between wild type strains. Furthermore, gene expression analyses revealed that CRK1 modulated the expression of genes involved in the progression of hyphal elongation, basidium formation, karyogamy and meiosis. Phenotypic results showed that, although deletion of C. neoformans CRK1 gene increased the efficiency of bisexual mating, filamentation in the crk1 mutant was blocked by MAT2 or ZNF2 mutation. A bioinformatics survey predicted the C. neoformans GATA transcriptional factor Gat1 as a potential substrate of Crk1 kinase. Our genetic and phenotypic findings revealed that C. neoformansGAT1 and CRK1 formed a regulatory circuit to negatively regulate MAT2 to control filamentation progression and transition during bisexual mating.


Subject(s)
Cryptococcus neoformans/genetics , Cyclin-Dependent Kinases/genetics , Genes, Mating Type, Fungal/genetics , Sex Differentiation/genetics , Cryptococcus neoformans/growth & development , Cryptococcus neoformans/pathogenicity , Fungal Proteins/genetics , Gene Expression Regulation, Fungal/genetics , Hyphae/genetics , Hyphae/growth & development , Meiosis/genetics , Mutation/genetics , Phosphorylation/genetics , Reproduction/genetics
18.
Curr Drug Metab ; 21(5): 379-389, 2020.
Article in English | MEDLINE | ID: mdl-32432999

ABSTRACT

BACKGROUND: This study aimed to reduce the amount of sulfobutylether-ß-cyclodextrin (SBECD) used in the marketed voriconazole injections to meet the clinical needs of patients with moderate-to-severe renal impairment (creatinine clearance rate <50 mL/min). OBJECTIVE: This study found that the surfactant Kolliphor® HS 15 (HS 15) and SBECD had significant synergistic effects on solubilizing voriconazole, and a novel voriconazole complex delivery system (VRC-CD/HS 15) was established. METHODS: The complex system was characterized, and its antifungal activity was studied by dynamic light scattering, dialysis bag method, disk diffusion, and broth microdilution. RESULTS: Compared with the control, its encapsulation efficiency (90.07±0.48%), drug loading (7.37±0.25%) and zeta potential (-4.36±1.37 mV) were increased by 1.54%, 41.19%, and 296.36%, respectively; its average particle size (13.92±0.00 nm) was reduced by 15.69%, so the complex system had better stability. Simultaneously, its drug release behavior was similar to that of the control, and it was a first-order kinetic model. Antifungal studies indicated that the complex system had noticeable antifungal effects. With the increase of drug concentration, the inhibition zone increased. The minimum inhibitory concentrations of the complex system against Cryptococcus neoformans, Aspergillus niger and Candida albicans were 0.0313 µg/mL, 1 µg/mL and 128 µg/mL, respectively. CONCLUSION: It showed a significant inhibitory effect on C. neoformans and had a visible therapeutic effect on Kunming mice infected with C. neoformans. Consequently, VRC-CD/HS 15 had better physicochemical properties and still had an apparent antifungal effect, and was promising as a potential alternative drug for clinical application.


Subject(s)
Antifungal Agents/administration & dosage , Cryptococcosis/drug therapy , Drug Carriers/administration & dosage , Polyethylene Glycols/administration & dosage , Stearates/administration & dosage , Surface-Active Agents/administration & dosage , Voriconazole/administration & dosage , beta-Cyclodextrins/administration & dosage , Animals , Antifungal Agents/chemistry , Aspergillus niger/drug effects , Aspergillus niger/growth & development , Candida albicans/drug effects , Candida albicans/growth & development , Cryptococcus neoformans/drug effects , Cryptococcus neoformans/growth & development , Drug Carriers/chemistry , Drug Liberation , Female , Male , Mice , Microbial Sensitivity Tests , Polyethylene Glycols/chemistry , Stearates/chemistry , Surface-Active Agents/chemistry , Voriconazole/chemistry , beta-Cyclodextrins/chemistry
19.
FEMS Yeast Res ; 20(3)2020 05 01.
Article in English | MEDLINE | ID: mdl-32391887

ABSTRACT

Cryptococcus neoformans is an important invasive fungal pathogen that causes life-threatening meningoencephalitis in humans. Its biological and pathogenic regulatory mechanisms remain largely unknown, particularly due to the presence of those core transcription factors (TFs). Here, we conducted a detailed characterization of the TF Liv4 in the biology and virulence of C. neoformans. Deletion of TF Liv4 protein resulted in growth defect under both normal and stress conditions (such as high temperature and cell wall/membrane damaging agents), drastic morphological damage and also attenuated virulence in C. neoformans. These phenotypic changes might be contributed to transcriptional abnormality in the liv4Δ mutant, in which several cryptococcal genes involved in energy metabolism and cell wall integrity were downregulated. Furthermore, ChIP-seq and ChIP-qPCR assays suggested TF Liv4 might exert its regulatory function in transcription by its activation of RBP1 in C. neoformans. Taken together, our work highlights the importance of TF Liv4 in the growth and virulence of C. neoformans, and it facilitates a better understanding of cryptococcal pathogenesis mechanisms.


Subject(s)
Cryptococcus neoformans/growth & development , Cryptococcus neoformans/genetics , Fungal Proteins/genetics , Gene Expression Regulation, Fungal , Transcription Factors/genetics , Animals , Cryptococcosis/microbiology , Cryptococcus neoformans/pathogenicity , Female , Fungal Proteins/metabolism , Gene Expression Profiling , Macrophages/microbiology , Mice , Mice, Inbred BALB C , Phenotype , Transcription Factors/metabolism , Virulence , Virulence Factors/genetics
20.
Genes (Basel) ; 11(4)2020 04 16.
Article in English | MEDLINE | ID: mdl-32316250

ABSTRACT

Cell size affects almost all biosynthetic processes by controlling the size of organelles and disrupting the nutrient uptake process. Yeast cells must reach a critical size to be able to enter a new cell cycle stage. Abnormal changes in cell size are often observed under pathological conditions such as cancer disease. Thus, cell size must be strictly controlled during cell cycle progression. Here, we reported that the highly conserved 5'-3' exonuclease Xrn1 could regulate the gene expression involved in the cell cycle pathway of Cryptococcus neoformans. Chromosomal deletion of XRN1 caused an increase in cell size, defects in cell growth and altered DNA content at 37 °C. RNA-sequencing results showed that the difference was significantly enriched in genes involved in membrane components, DNA metabolism, integration and recombination, DNA polymerase activity, meiotic cell cycle, nuclear division, organelle fission, microtubule-based process and reproduction. In addition, the proportion of the differentially expressed periodic genes was up to 19.8% when XRN1 was deleted, including cell cycle-related genes, chitin synthase genes and transcription factors, indicating the important role of Xrn1 in the control of cell cycle. This work provides insights into the roles of RNA decay factor Xrn1 in maintaining appropriate cell size, DNA content and cell cycle progression.


Subject(s)
Cell Division , Cryptococcosis/microbiology , Cryptococcus neoformans/growth & development , Exonucleases/metabolism , Fungal Proteins/metabolism , Gene Expression Regulation, Fungal , RNA, Messenger/metabolism , Cryptococcus neoformans/genetics , Cryptococcus neoformans/metabolism , Exonucleases/genetics , Fungal Proteins/genetics , Humans , RNA, Messenger/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...